Know Cancer

or
forgot password

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data


N/A
N/A
N/A
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data


Inclusion Criteria:



Patients in the first retrospective study (Stage 1) must be part of the 409 patient strong
MSKCC cohort with progressive metastatic prostate cancer which was used for the generation
of the original nomogram.

For details please see original publication by Smaletz et al. Patients involved in the
second retrospective study (Stage 2) must be part of the 223 patients with a rising PSA
after surgery or radiation therapy who were treated on conjugate vaccine trials at MSKCC..

Exclusion Criteria:

For details of excluded patients on the clinical metastases castrate disease study, please
see original publication by Smaletz et al.4

• (MSKCC - add reference if publication available for rising PSA patients)

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

The analysis for the progressive castrate mets disease population consists of two analytical steps. The first step involved the development of a predictive model of pt survival using supervised multivariate analytical (SMA)techniques

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Howard I Scher, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

04-062

NCT ID:

NCT00578409

Start Date:

May 2004

Completion Date:

April 2010

Related Keywords:

  • Prostate Cancer
  • castration resistant prostate cancer
  • progressive castrate metastatic prostate cancer
  • Prostatic Neoplasms

Name

Location
Memorial Sloan-Kettering Cancer Center New York, New York  10021